PDL-1

Clinical trials for PDL-1 explained in plain language.

Never miss a new study

Get alerted when new PDL-1 trials appear

Sign up with your email to follow new studies for PDL-1, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

Triple-Drug attack on Hard-to-Treat stomach cancer shows promise in early trial

Disease control Recruiting now

This Phase II trial is testing a combination of three drugs—zanidatamab, pembrolizumab, and chemotherapy—in 80 people with advanced stomach or esophageal cancer that has spread and tests positive for HER2 and PD-L1. The goal is to see if this triple therapy can keep the cancer fr…

Matched conditions: PDL-1

Phase: PHASE2 • Sponsor: Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest • Aim: Disease control

Last updated Jul 02, 2026 00:00 UTC

PDL-1

Get alerted when new PDL-1 trials appear

Triple-Drug attack on Hard-to-Treat stomach cancer shows promise in early trial